Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Net Income (2018 - 2025)

Historic Net Income for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to -$4.8 million.

  • Dna X's Net Income fell 8921.18% to -$4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$34.0 million, marking a year-over-year decrease of 16253.66%. This contributed to the annual value of -$34.3 million for FY2024, which is 1033701.49% down from last year.
  • Latest data reveals that Dna X reported Net Income of -$4.8 million as of Q3 2025, which was down 8921.18% from -$7.5 million recorded in Q2 2025.
  • In the past 5 years, Dna X's Net Income registered a high of $527000.0 during Q3 2023, and its lowest value of -$22.3 million during Q4 2024.
  • For the 5-year period, Dna X's Net Income averaged around -$5.2 million, with its median value being -$4.2 million (2022).
  • In the last 5 years, Dna X's Net Income surged by 13277.36% in 2023 and then tumbled by 229870.69% in 2024.
  • Over the past 5 years, Dna X's Net Income (Quarter) stood at -$11.7 million in 2021, then surged by 89.91% to -$1.2 million in 2022, then rose by 21.69% to -$928000.0 in 2023, then plummeted by 2298.71% to -$22.3 million in 2024, then surged by 78.65% to -$4.8 million in 2025.
  • Its last three reported values are -$4.8 million in Q3 2025, -$7.5 million for Q2 2025, and $458000.0 during Q1 2025.